Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital

mutations in patients with advanced NSCLC in a large comprehensive cancer center in Korea.Our retrospective cohort included 1,503 NSCLC patients aged ≥18 years, with stage IIIB/IV disease, who attended the Samsung Medical Center in Seoul, Korea, from January 2007 through July 2010. Trained oncology nurses reviewed and abstracted data from electronic medical records. mutation positive patients were more likely to be female, never-smokers, never-drinkers and to have adenocarcinoma. mutation positive cases warrants the need for generalized testing in Asian NSCLC patients